182 related articles for article (PubMed ID: 16506353)
1. Safety and efficacy of eletriptan in the treatment of acute migraine.
Takiya L; Piccininni LC; Kamath V
Pharmacotherapy; 2006 Jan; 26(1):115-28. PubMed ID: 16506353
[TBL] [Abstract][Full Text] [Related]
2. Eletriptan: a review of its use in the acute treatment of migraine.
McCormack PL; Keating GM
Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799
[TBL] [Abstract][Full Text] [Related]
3. Spotlight on eletriptan in migraine.
McCormack PL; Keating GM
CNS Drugs; 2006; 20(11):961-4. PubMed ID: 17044732
[TBL] [Abstract][Full Text] [Related]
4. Eletriptan.
Gawel MJ; Grujich NN
Expert Opin Investig Drugs; 2001 Oct; 10(10):1869-74. PubMed ID: 11772292
[TBL] [Abstract][Full Text] [Related]
5. Eletriptan.
Sandrini G; Perrotta A; Tassorelli C; Nappi G
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1587-98. PubMed ID: 19929447
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and safety of eletriptan in the treatment of migraine: a comprehensive review.
Mathew NT; Hettiarachchi J; Alderman J
Headache; 2003 Oct; 43(9):962-74. PubMed ID: 14511273
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
Diener HC; Jansen JP; Reches A; Pascual J; Pitei D; Steiner TJ;
Eur Neurol; 2002; 47(2):99-107. PubMed ID: 11844898
[TBL] [Abstract][Full Text] [Related]
8. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
[TBL] [Abstract][Full Text] [Related]
9. Eletriptan review.
Färkkilä M; Kallela M
Expert Opin Pharmacother; 2005 Apr; 6(4):625-30. PubMed ID: 15934888
[TBL] [Abstract][Full Text] [Related]
10. Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
Bhambri R; Martin VT; Abdulsattar Y; Silberstein S; Almas M; Chatterjee A; Ramos E
Headache; 2014 Feb; 54(2):343-54. PubMed ID: 24256184
[TBL] [Abstract][Full Text] [Related]
11. Eletriptan: a review and new perspectives.
Sandrini G; Perrotta A; Nappi G
Expert Rev Neurother; 2006 Oct; 6(10):1413-21. PubMed ID: 17078782
[TBL] [Abstract][Full Text] [Related]
12. Eletriptan in migraine.
Diener HC
Expert Rev Neurother; 2005 Jan; 5(1):43-53. PubMed ID: 15853473
[TBL] [Abstract][Full Text] [Related]
13. Eletriptan for acute migraine.
Smith LA; Oldman AD; McQuay HJ; Moore RA
Cochrane Database Syst Rev; 2001; (3):CD003224. PubMed ID: 11687056
[TBL] [Abstract][Full Text] [Related]
14. WITHDRAWN: Eletriptan for acute migraine.
Smith LA; Oldman AD; McQuay HJ; Moore RA
Cochrane Database Syst Rev; 2007 Jul; 2001(1):CD003224. PubMed ID: 17636718
[TBL] [Abstract][Full Text] [Related]
15. Patient satisfaction with eletriptan in the acute treatment of migraine in primary care.
Nett RB; Tiseo PJ; Almas M; Sikes CR
Int J Clin Pract; 2007 Oct; 61(10):1677-85. PubMed ID: 17877653
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety, and tolerability of oral eletriptan for treatment of acute migraine: a multicenter, double-blind, placebo-controlled study conducted in the United States.
Sheftell F; Ryan R; Pitman V;
Headache; 2003 Mar; 43(3):202-13. PubMed ID: 12603638
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological, pharmacokinetic and clinical profile of eletriptan (Relpax), a new triptan for migraine].
Omote M
Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):93-101. PubMed ID: 12843576
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.
Garcia-Ramos G; MacGregor EA; Hilliard B; Bordini CA; Leston J; Hettiarachchi J
Cephalalgia; 2003 Nov; 23(9):869-76. PubMed ID: 14616928
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology and efficacy of eletriptan for the treatment of migraine attacks.
Diener HC; McHarg A
Int J Clin Pract; 2000 Dec; 54(10):670-4. PubMed ID: 11221281
[TBL] [Abstract][Full Text] [Related]
20. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
McCormack PL; Foster RH
Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
